MusclePharm launches MMA Elite supplement line at Walmart
DENVER — MusclePharm on Thursday announced its MMA Elite supplements powered by MusclePharm now are available in select Walmart stores. With the new partnership between MMA Elite — a mixed-martials arts brand licensed by Ultimate Brand Management — and MusclePharm, the new supplement line will be released in the Las Vegas area first and will then spread nationwide.
The first two products to be featured are Perform Elite, a pre-workout product, and Recover Elite, a post-workout supplement, at a suggested retail price of $19.97 each.
MMA Elite powered by MusclePharm is a supplement line that will feature formulations from MusclePharm, a sports nutrition company that also is the official nutritional supplement provider of the Ultimate Fighting Championship. MMA Elite is a clothing brand that is available exclusively at Walmart and also is a UFC partner.
"We want to make sure our brand is in the position to cover and be available to consumers on every retail level of the sports nutrition market. Walmart customers have enjoyed the MMA Elite clothing brand for a number of years and now we are thrilled to bring them a high-quality sports nutrition line," stated MusclePharm CEO Brad Pyatt.
FDA issues warning on PPI, H2 blocker antacids: May increase risk of CDAD
SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.
Patients should immediately contact their healthcare professional and seek care if they take PPIs and develop diarrhea that does not improve, the agency stated.
Clostridium difficile is a bacterium that can cause diarrhea that does not improve. Symptoms include watery stool, abdominal pain and fever, and patients may go on to develop more serious intestinal conditions. The disease also can be spread in the hospital. Factors that may predispose an individual to developing CDAD include advanced age, certain chronic medical conditions and taking broad spectrum antibiotics. Treatment for CDAD includes the replacement of fluids and electrolytes and the use of special antibiotics.
The FDA is working with manufacturers to include information about the increased risk of CDAD with use of PPIs in the drug labels, the agency said.
To review the safety announcement, and for a full list of both prescription and over-the-counter brands included in the warning, click here.
Walgreens direct messaging those social consumers ‘checking in’ at its stores
NEW YORK — Walgreens in January has been utilizing a new mobile advertising tool to push out messages targeting consumers who just "checked in" at one of its locations, according to a report published in Ad Age Wednesday.
According to the report, Walgreens sent out 5,000 messages in January via Twitter stating: "Check out Halls’ new cough drops in the cold aisle."
The tool is startup LocalResponse, and Walgreens is credited with being the first retailer to use the new service to publish deals or promotions for consumer packaged goods. Walgreens has an exclusive with LocalResponse for one year, the report added.